nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR6—Raloxifene—osteoporosis	0.157	0.261	CbGbCtD
Bromocriptine—HTR2B—Raloxifene—osteoporosis	0.14	0.233	CbGbCtD
Bromocriptine—CYP1A2—Estropipate—osteoporosis	0.0497	0.0827	CbGbCtD
Bromocriptine—ABCB1—Ethinyl Estradiol—osteoporosis	0.028	0.0466	CbGbCtD
Bromocriptine—CYP3A4—Estropipate—osteoporosis	0.026	0.0433	CbGbCtD
Bromocriptine—CYP3A4—Calcitriol—osteoporosis	0.026	0.0433	CbGbCtD
Bromocriptine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0235	0.0391	CbGbCtD
Bromocriptine—CYP3A4—Ergocalciferol—osteoporosis	0.0208	0.0346	CbGbCtD
Bromocriptine—CYP1A2—Estradiol—osteoporosis	0.0206	0.0343	CbGbCtD
Bromocriptine—ABCB1—Conjugated Estrogens—osteoporosis	0.0205	0.0342	CbGbCtD
Bromocriptine—ABCB1—Estradiol—osteoporosis	0.018	0.03	CbGbCtD
Bromocriptine—CYP3A4—Raloxifene—osteoporosis	0.0174	0.0289	CbGbCtD
Bromocriptine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0168	0.0279	CbGbCtD
Bromocriptine—CYP3A4—Cholecalciferol—osteoporosis	0.0134	0.0223	CbGbCtD
Bromocriptine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0123	0.0205	CbGbCtD
Bromocriptine—CYP3A4—Estradiol—osteoporosis	0.0108	0.018	CbGbCtD
Bromocriptine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000347	0.00125	CcSEcCtD
Bromocriptine—Sinusitis—Estradiol—osteoporosis	0.000347	0.00125	CcSEcCtD
Bromocriptine—Shock—Risedronate—osteoporosis	0.000347	0.00125	CcSEcCtD
Bromocriptine—Nervous system disorder—Risedronate—osteoporosis	0.000345	0.00125	CcSEcCtD
Bromocriptine—Agitation—Zoledronate—osteoporosis	0.000344	0.00124	CcSEcCtD
Bromocriptine—Skin disorder—Risedronate—osteoporosis	0.000342	0.00123	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000342	0.00123	CcSEcCtD
Bromocriptine—Abdominal pain—Raloxifene—osteoporosis	0.000341	0.00123	CcSEcCtD
Bromocriptine—Body temperature increased—Raloxifene—osteoporosis	0.000341	0.00123	CcSEcCtD
Bromocriptine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00034	0.00123	CcSEcCtD
Bromocriptine—Urticaria—Ibandronate—osteoporosis	0.00034	0.00123	CcSEcCtD
Bromocriptine—Abdominal pain—Ibandronate—osteoporosis	0.000338	0.00122	CcSEcCtD
Bromocriptine—Body temperature increased—Ibandronate—osteoporosis	0.000338	0.00122	CcSEcCtD
Bromocriptine—Confusional state—Pamidronate—osteoporosis	0.000338	0.00122	CcSEcCtD
Bromocriptine—Vertigo—Zoledronate—osteoporosis	0.000337	0.00121	CcSEcCtD
Bromocriptine—Syncope—Zoledronate—osteoporosis	0.000336	0.00121	CcSEcCtD
Bromocriptine—Oedema—Pamidronate—osteoporosis	0.000335	0.00121	CcSEcCtD
Bromocriptine—Infection—Pamidronate—osteoporosis	0.000333	0.0012	CcSEcCtD
Bromocriptine—Rhinitis—Estradiol—osteoporosis	0.000333	0.0012	CcSEcCtD
Bromocriptine—Urticaria—Calcitriol—osteoporosis	0.000332	0.0012	CcSEcCtD
Bromocriptine—Body temperature increased—Calcitriol—osteoporosis	0.000331	0.00119	CcSEcCtD
Bromocriptine—Abdominal pain—Calcitriol—osteoporosis	0.000331	0.00119	CcSEcCtD
Bromocriptine—Hypoaesthesia—Estradiol—osteoporosis	0.00033	0.00119	CcSEcCtD
Bromocriptine—Shock—Pamidronate—osteoporosis	0.000329	0.00119	CcSEcCtD
Bromocriptine—Loss of consciousness—Zoledronate—osteoporosis	0.000329	0.00119	CcSEcCtD
Bromocriptine—Nervous system disorder—Pamidronate—osteoporosis	0.000328	0.00118	CcSEcCtD
Bromocriptine—Vomiting—Etidronic acid—osteoporosis	0.000328	0.00118	CcSEcCtD
Bromocriptine—Oedema peripheral—Estradiol—osteoporosis	0.000327	0.00118	CcSEcCtD
Bromocriptine—Tachycardia—Pamidronate—osteoporosis	0.000327	0.00118	CcSEcCtD
Bromocriptine—Connective tissue disorder—Estradiol—osteoporosis	0.000326	0.00118	CcSEcCtD
Bromocriptine—Rash—Etidronic acid—osteoporosis	0.000325	0.00117	CcSEcCtD
Bromocriptine—Convulsion—Zoledronate—osteoporosis	0.000325	0.00117	CcSEcCtD
Bromocriptine—Dermatitis—Etidronic acid—osteoporosis	0.000325	0.00117	CcSEcCtD
Bromocriptine—Vertigo—Conjugated Estrogens—osteoporosis	0.000324	0.00117	CcSEcCtD
Bromocriptine—Syncope—Conjugated Estrogens—osteoporosis	0.000324	0.00117	CcSEcCtD
Bromocriptine—Hypertension—Zoledronate—osteoporosis	0.000324	0.00117	CcSEcCtD
Bromocriptine—Headache—Etidronic acid—osteoporosis	0.000323	0.00116	CcSEcCtD
Bromocriptine—Asthenia—Estropipate—osteoporosis	0.00032	0.00115	CcSEcCtD
Bromocriptine—Visual impairment—Estradiol—osteoporosis	0.00032	0.00115	CcSEcCtD
Bromocriptine—Anorexia—Pamidronate—osteoporosis	0.000319	0.00115	CcSEcCtD
Bromocriptine—Insomnia—Risedronate—osteoporosis	0.000319	0.00115	CcSEcCtD
Bromocriptine—Anxiety—Zoledronate—osteoporosis	0.000318	0.00115	CcSEcCtD
Bromocriptine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000317	0.00114	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000317	0.00114	CcSEcCtD
Bromocriptine—Paraesthesia—Risedronate—osteoporosis	0.000316	0.00114	CcSEcCtD
Bromocriptine—Asthenia—Alendronate—osteoporosis	0.000315	0.00114	CcSEcCtD
Bromocriptine—Dyspnoea—Risedronate—osteoporosis	0.000314	0.00113	CcSEcCtD
Bromocriptine—Hypotension—Pamidronate—osteoporosis	0.000313	0.00113	CcSEcCtD
Bromocriptine—Convulsion—Conjugated Estrogens—osteoporosis	0.000313	0.00113	CcSEcCtD
Bromocriptine—Dry mouth—Zoledronate—osteoporosis	0.000312	0.00113	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000312	0.00113	CcSEcCtD
Bromocriptine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000312	0.00112	CcSEcCtD
Bromocriptine—Dyspepsia—Risedronate—osteoporosis	0.00031	0.00112	CcSEcCtD
Bromocriptine—Eye disorder—Estradiol—osteoporosis	0.00031	0.00112	CcSEcCtD
Bromocriptine—Tinnitus—Estradiol—osteoporosis	0.000309	0.00112	CcSEcCtD
Bromocriptine—Constipation—Ethinyl Estradiol—osteoporosis	0.000309	0.00111	CcSEcCtD
Bromocriptine—Confusional state—Zoledronate—osteoporosis	0.000308	0.00111	CcSEcCtD
Bromocriptine—Cardiac disorder—Estradiol—osteoporosis	0.000308	0.00111	CcSEcCtD
Bromocriptine—Asthenia—Ibandronate—osteoporosis	0.000307	0.00111	CcSEcCtD
Bromocriptine—Anxiety—Conjugated Estrogens—osteoporosis	0.000306	0.0011	CcSEcCtD
Bromocriptine—Nausea—Etidronic acid—osteoporosis	0.000306	0.0011	CcSEcCtD
Bromocriptine—Oedema—Zoledronate—osteoporosis	0.000306	0.0011	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000305	0.0011	CcSEcCtD
Bromocriptine—Diarrhoea—Estropipate—osteoporosis	0.000305	0.0011	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000304	0.0011	CcSEcCtD
Bromocriptine—Infection—Zoledronate—osteoporosis	0.000304	0.0011	CcSEcCtD
Bromocriptine—Fatigue—Risedronate—osteoporosis	0.000304	0.0011	CcSEcCtD
Bromocriptine—Insomnia—Pamidronate—osteoporosis	0.000303	0.00109	CcSEcCtD
Bromocriptine—Constipation—Risedronate—osteoporosis	0.000301	0.00109	CcSEcCtD
Bromocriptine—Angiopathy—Estradiol—osteoporosis	0.000301	0.00109	CcSEcCtD
Bromocriptine—Shock—Zoledronate—osteoporosis	0.000301	0.00109	CcSEcCtD
Bromocriptine—Paraesthesia—Pamidronate—osteoporosis	0.000301	0.00108	CcSEcCtD
Bromocriptine—Diarrhoea—Alendronate—osteoporosis	0.0003	0.00108	CcSEcCtD
Bromocriptine—Asthenia—Calcitriol—osteoporosis	0.0003	0.00108	CcSEcCtD
Bromocriptine—Nervous system disorder—Zoledronate—osteoporosis	0.0003	0.00108	CcSEcCtD
Bromocriptine—Mediastinal disorder—Estradiol—osteoporosis	0.000299	0.00108	CcSEcCtD
Bromocriptine—Dyspnoea—Pamidronate—osteoporosis	0.000299	0.00108	CcSEcCtD
Bromocriptine—Tachycardia—Zoledronate—osteoporosis	0.000299	0.00108	CcSEcCtD
Bromocriptine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000298	0.00107	CcSEcCtD
Bromocriptine—Somnolence—Pamidronate—osteoporosis	0.000298	0.00107	CcSEcCtD
Bromocriptine—Skin disorder—Zoledronate—osteoporosis	0.000297	0.00107	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000295	0.00107	CcSEcCtD
Bromocriptine—Diarrhoea—Raloxifene—osteoporosis	0.000295	0.00107	CcSEcCtD
Bromocriptine—Dyspepsia—Pamidronate—osteoporosis	0.000295	0.00106	CcSEcCtD
Bromocriptine—Dizziness—Estropipate—osteoporosis	0.000295	0.00106	CcSEcCtD
Bromocriptine—Oedema—Conjugated Estrogens—osteoporosis	0.000295	0.00106	CcSEcCtD
Bromocriptine—Alopecia—Estradiol—osteoporosis	0.000293	0.00106	CcSEcCtD
Bromocriptine—Infection—Conjugated Estrogens—osteoporosis	0.000293	0.00106	CcSEcCtD
Bromocriptine—Diarrhoea—Ibandronate—osteoporosis	0.000292	0.00106	CcSEcCtD
Bromocriptine—Anorexia—Zoledronate—osteoporosis	0.000292	0.00105	CcSEcCtD
Bromocriptine—Decreased appetite—Pamidronate—osteoporosis	0.000291	0.00105	CcSEcCtD
Bromocriptine—Mental disorder—Estradiol—osteoporosis	0.000291	0.00105	CcSEcCtD
Bromocriptine—Dizziness—Alendronate—osteoporosis	0.00029	0.00105	CcSEcCtD
Bromocriptine—Shock—Conjugated Estrogens—osteoporosis	0.00029	0.00105	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000289	0.00104	CcSEcCtD
Bromocriptine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000289	0.00104	CcSEcCtD
Bromocriptine—Fatigue—Pamidronate—osteoporosis	0.000289	0.00104	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Risedronate—osteoporosis	0.000288	0.00104	CcSEcCtD
Bromocriptine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000287	0.00104	CcSEcCtD
Bromocriptine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000287	0.00104	CcSEcCtD
Bromocriptine—Constipation—Pamidronate—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Diarrhoea—Calcitriol—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Hypotension—Zoledronate—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Dizziness—Raloxifene—osteoporosis	0.000286	0.00103	CcSEcCtD
Bromocriptine—Tension—Estradiol—osteoporosis	0.000283	0.00102	CcSEcCtD
Bromocriptine—Vomiting—Estropipate—osteoporosis	0.000283	0.00102	CcSEcCtD
Bromocriptine—Dysgeusia—Estradiol—osteoporosis	0.000283	0.00102	CcSEcCtD
Bromocriptine—Dizziness—Ibandronate—osteoporosis	0.000283	0.00102	CcSEcCtD
Bromocriptine—Rash—Estropipate—osteoporosis	0.000281	0.00101	CcSEcCtD
Bromocriptine—Dermatitis—Estropipate—osteoporosis	0.000281	0.00101	CcSEcCtD
Bromocriptine—Anorexia—Conjugated Estrogens—osteoporosis	0.000281	0.00101	CcSEcCtD
Bromocriptine—Nervousness—Estradiol—osteoporosis	0.000281	0.00101	CcSEcCtD
Bromocriptine—Urticaria—Risedronate—osteoporosis	0.00028	0.00101	CcSEcCtD
Bromocriptine—Headache—Estropipate—osteoporosis	0.000279	0.00101	CcSEcCtD
Bromocriptine—Vomiting—Alendronate—osteoporosis	0.000279	0.00101	CcSEcCtD
Bromocriptine—Abdominal pain—Risedronate—osteoporosis	0.000278	0.001	CcSEcCtD
Bromocriptine—Body temperature increased—Risedronate—osteoporosis	0.000278	0.001	CcSEcCtD
Bromocriptine—Muscle spasms—Estradiol—osteoporosis	0.000278	0.001	CcSEcCtD
Bromocriptine—Rash—Alendronate—osteoporosis	0.000277	0.000999	CcSEcCtD
Bromocriptine—Insomnia—Zoledronate—osteoporosis	0.000277	0.000998	CcSEcCtD
Bromocriptine—Dermatitis—Alendronate—osteoporosis	0.000277	0.000998	CcSEcCtD
Bromocriptine—Feeling abnormal—Pamidronate—osteoporosis	0.000276	0.000996	CcSEcCtD
Bromocriptine—Hypotension—Conjugated Estrogens—osteoporosis	0.000275	0.000993	CcSEcCtD
Bromocriptine—Headache—Alendronate—osteoporosis	0.000275	0.000992	CcSEcCtD
Bromocriptine—Paraesthesia—Zoledronate—osteoporosis	0.000275	0.000991	CcSEcCtD
Bromocriptine—Vomiting—Raloxifene—osteoporosis	0.000275	0.00099	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000274	0.000988	CcSEcCtD
Bromocriptine—Dyspnoea—Zoledronate—osteoporosis	0.000273	0.000984	CcSEcCtD
Bromocriptine—Rash—Raloxifene—osteoporosis	0.000272	0.000982	CcSEcCtD
Bromocriptine—Dermatitis—Raloxifene—osteoporosis	0.000272	0.000981	CcSEcCtD
Bromocriptine—Somnolence—Zoledronate—osteoporosis	0.000272	0.000981	CcSEcCtD
Bromocriptine—Vomiting—Ibandronate—osteoporosis	0.000272	0.000981	CcSEcCtD
Bromocriptine—Headache—Raloxifene—osteoporosis	0.000271	0.000976	CcSEcCtD
Bromocriptine—Rash—Ibandronate—osteoporosis	0.00027	0.000972	CcSEcCtD
Bromocriptine—Dermatitis—Ibandronate—osteoporosis	0.000269	0.000971	CcSEcCtD
Bromocriptine—Dyspepsia—Zoledronate—osteoporosis	0.000269	0.000971	CcSEcCtD
Bromocriptine—Headache—Ibandronate—osteoporosis	0.000268	0.000966	CcSEcCtD
Bromocriptine—Insomnia—Conjugated Estrogens—osteoporosis	0.000266	0.000961	CcSEcCtD
Bromocriptine—Vomiting—Calcitriol—osteoporosis	0.000266	0.00096	CcSEcCtD
Bromocriptine—Decreased appetite—Zoledronate—osteoporosis	0.000266	0.000959	CcSEcCtD
Bromocriptine—Agitation—Estradiol—osteoporosis	0.000265	0.000958	CcSEcCtD
Bromocriptine—Nausea—Estropipate—osteoporosis	0.000265	0.000955	CcSEcCtD
Bromocriptine—Abdominal pain—Pamidronate—osteoporosis	0.000265	0.000955	CcSEcCtD
Bromocriptine—Body temperature increased—Pamidronate—osteoporosis	0.000265	0.000955	CcSEcCtD
Bromocriptine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000264	0.000954	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000264	0.000953	CcSEcCtD
Bromocriptine—Rash—Calcitriol—osteoporosis	0.000264	0.000952	CcSEcCtD
Bromocriptine—Fatigue—Zoledronate—osteoporosis	0.000264	0.000951	CcSEcCtD
Bromocriptine—Dermatitis—Calcitriol—osteoporosis	0.000264	0.000951	CcSEcCtD
Bromocriptine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000263	0.000947	CcSEcCtD
Bromocriptine—Headache—Calcitriol—osteoporosis	0.000262	0.000946	CcSEcCtD
Bromocriptine—Somnolence—Conjugated Estrogens—osteoporosis	0.000262	0.000945	CcSEcCtD
Bromocriptine—Constipation—Zoledronate—osteoporosis	0.000262	0.000944	CcSEcCtD
Bromocriptine—Nausea—Alendronate—osteoporosis	0.000261	0.000941	CcSEcCtD
Bromocriptine—Vertigo—Estradiol—osteoporosis	0.00026	0.000936	CcSEcCtD
Bromocriptine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000259	0.000935	CcSEcCtD
Bromocriptine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000259	0.000935	CcSEcCtD
Bromocriptine—Syncope—Estradiol—osteoporosis	0.000259	0.000935	CcSEcCtD
Bromocriptine—Nausea—Raloxifene—osteoporosis	0.000256	0.000925	CcSEcCtD
Bromocriptine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000256	0.000924	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000254	0.000917	CcSEcCtD
Bromocriptine—Fatigue—Conjugated Estrogens—osteoporosis	0.000254	0.000916	CcSEcCtD
Bromocriptine—Nausea—Ibandronate—osteoporosis	0.000254	0.000916	CcSEcCtD
Bromocriptine—Loss of consciousness—Estradiol—osteoporosis	0.000254	0.000916	CcSEcCtD
Bromocriptine—Asthenia—Risedronate—osteoporosis	0.000253	0.000912	CcSEcCtD
Bromocriptine—Feeling abnormal—Zoledronate—osteoporosis	0.000252	0.000909	CcSEcCtD
Bromocriptine—Constipation—Conjugated Estrogens—osteoporosis	0.000252	0.000909	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Zoledronate—osteoporosis	0.00025	0.000902	CcSEcCtD
Bromocriptine—Hypertension—Estradiol—osteoporosis	0.000249	0.0009	CcSEcCtD
Bromocriptine—Nausea—Calcitriol—osteoporosis	0.000249	0.000897	CcSEcCtD
Bromocriptine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000247	0.000892	CcSEcCtD
Bromocriptine—Anxiety—Estradiol—osteoporosis	0.000245	0.000884	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000244	0.000881	CcSEcCtD
Bromocriptine—Urticaria—Zoledronate—osteoporosis	0.000243	0.000877	CcSEcCtD
Bromocriptine—Abdominal pain—Zoledronate—osteoporosis	0.000242	0.000872	CcSEcCtD
Bromocriptine—Body temperature increased—Zoledronate—osteoporosis	0.000242	0.000872	CcSEcCtD
Bromocriptine—Diarrhoea—Risedronate—osteoporosis	0.000241	0.00087	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000241	0.000869	CcSEcCtD
Bromocriptine—Dry mouth—Estradiol—osteoporosis	0.000241	0.000868	CcSEcCtD
Bromocriptine—Asthenia—Pamidronate—osteoporosis	0.00024	0.000867	CcSEcCtD
Bromocriptine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000239	0.000862	CcSEcCtD
Bromocriptine—Confusional state—Estradiol—osteoporosis	0.000238	0.000858	CcSEcCtD
Bromocriptine—Oedema—Estradiol—osteoporosis	0.000236	0.00085	CcSEcCtD
Bromocriptine—Infection—Estradiol—osteoporosis	0.000234	0.000845	CcSEcCtD
Bromocriptine—Urticaria—Conjugated Estrogens—osteoporosis	0.000234	0.000844	CcSEcCtD
Bromocriptine—Dizziness—Risedronate—osteoporosis	0.000233	0.00084	CcSEcCtD
Bromocriptine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000233	0.00084	CcSEcCtD
Bromocriptine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000233	0.00084	CcSEcCtD
Bromocriptine—Shock—Estradiol—osteoporosis	0.000232	0.000837	CcSEcCtD
Bromocriptine—Nervous system disorder—Estradiol—osteoporosis	0.000231	0.000834	CcSEcCtD
Bromocriptine—Tachycardia—Estradiol—osteoporosis	0.00023	0.00083	CcSEcCtD
Bromocriptine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00023	0.000829	CcSEcCtD
Bromocriptine—Diarrhoea—Pamidronate—osteoporosis	0.000229	0.000827	CcSEcCtD
Bromocriptine—Skin disorder—Estradiol—osteoporosis	0.000229	0.000826	CcSEcCtD
Bromocriptine—Rash—Ethinyl Estradiol—osteoporosis	0.000228	0.000822	CcSEcCtD
Bromocriptine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000228	0.000821	CcSEcCtD
Bromocriptine—Headache—Ethinyl Estradiol—osteoporosis	0.000226	0.000817	CcSEcCtD
Bromocriptine—Vomiting—Risedronate—osteoporosis	0.000224	0.000808	CcSEcCtD
Bromocriptine—Rash—Risedronate—osteoporosis	0.000222	0.000801	CcSEcCtD
Bromocriptine—Dermatitis—Risedronate—osteoporosis	0.000222	0.000801	CcSEcCtD
Bromocriptine—Dizziness—Pamidronate—osteoporosis	0.000221	0.000799	CcSEcCtD
Bromocriptine—Headache—Risedronate—osteoporosis	0.000221	0.000796	CcSEcCtD
Bromocriptine—Asthenia—Zoledronate—osteoporosis	0.000219	0.000792	CcSEcCtD
Bromocriptine—Nausea—Ethinyl Estradiol—osteoporosis	0.000215	0.000774	CcSEcCtD
Bromocriptine—Insomnia—Estradiol—osteoporosis	0.000213	0.000769	CcSEcCtD
Bromocriptine—Vomiting—Pamidronate—osteoporosis	0.000213	0.000768	CcSEcCtD
Bromocriptine—Paraesthesia—Estradiol—osteoporosis	0.000212	0.000764	CcSEcCtD
Bromocriptine—Asthenia—Conjugated Estrogens—osteoporosis	0.000211	0.000762	CcSEcCtD
Bromocriptine—Rash—Pamidronate—osteoporosis	0.000211	0.000762	CcSEcCtD
Bromocriptine—Dermatitis—Pamidronate—osteoporosis	0.000211	0.000761	CcSEcCtD
Bromocriptine—Dyspnoea—Estradiol—osteoporosis	0.00021	0.000758	CcSEcCtD
Bromocriptine—Headache—Pamidronate—osteoporosis	0.00021	0.000757	CcSEcCtD
Bromocriptine—Somnolence—Estradiol—osteoporosis	0.00021	0.000756	CcSEcCtD
Bromocriptine—Diarrhoea—Zoledronate—osteoporosis	0.000209	0.000755	CcSEcCtD
Bromocriptine—Nausea—Risedronate—osteoporosis	0.000209	0.000755	CcSEcCtD
Bromocriptine—Dyspepsia—Estradiol—osteoporosis	0.000208	0.000749	CcSEcCtD
Bromocriptine—Decreased appetite—Estradiol—osteoporosis	0.000205	0.000739	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000204	0.000734	CcSEcCtD
Bromocriptine—Fatigue—Estradiol—osteoporosis	0.000203	0.000733	CcSEcCtD
Bromocriptine—Dizziness—Zoledronate—osteoporosis	0.000202	0.00073	CcSEcCtD
Bromocriptine—Constipation—Estradiol—osteoporosis	0.000202	0.000727	CcSEcCtD
Bromocriptine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000202	0.000727	CcSEcCtD
Bromocriptine—Nausea—Pamidronate—osteoporosis	0.000199	0.000718	CcSEcCtD
Bromocriptine—Dizziness—Conjugated Estrogens—osteoporosis	0.000195	0.000703	CcSEcCtD
Bromocriptine—Vomiting—Zoledronate—osteoporosis	0.000194	0.000702	CcSEcCtD
Bromocriptine—Feeling abnormal—Estradiol—osteoporosis	0.000194	0.000701	CcSEcCtD
Bromocriptine—Rash—Zoledronate—osteoporosis	0.000193	0.000696	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Estradiol—osteoporosis	0.000193	0.000695	CcSEcCtD
Bromocriptine—Dermatitis—Zoledronate—osteoporosis	0.000193	0.000695	CcSEcCtD
Bromocriptine—Headache—Zoledronate—osteoporosis	0.000192	0.000691	CcSEcCtD
Bromocriptine—Vomiting—Conjugated Estrogens—osteoporosis	0.000187	0.000676	CcSEcCtD
Bromocriptine—Urticaria—Estradiol—osteoporosis	0.000187	0.000676	CcSEcCtD
Bromocriptine—Body temperature increased—Estradiol—osteoporosis	0.000186	0.000672	CcSEcCtD
Bromocriptine—Abdominal pain—Estradiol—osteoporosis	0.000186	0.000672	CcSEcCtD
Bromocriptine—Rash—Conjugated Estrogens—osteoporosis	0.000186	0.00067	CcSEcCtD
Bromocriptine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000186	0.000669	CcSEcCtD
Bromocriptine—Headache—Conjugated Estrogens—osteoporosis	0.000185	0.000666	CcSEcCtD
Bromocriptine—Nausea—Zoledronate—osteoporosis	0.000182	0.000656	CcSEcCtD
Bromocriptine—Nausea—Conjugated Estrogens—osteoporosis	0.000175	0.000631	CcSEcCtD
Bromocriptine—Asthenia—Estradiol—osteoporosis	0.000169	0.00061	CcSEcCtD
Bromocriptine—Diarrhoea—Estradiol—osteoporosis	0.000161	0.000582	CcSEcCtD
Bromocriptine—Dizziness—Estradiol—osteoporosis	0.000156	0.000562	CcSEcCtD
Bromocriptine—Vomiting—Estradiol—osteoporosis	0.00015	0.000541	CcSEcCtD
Bromocriptine—Rash—Estradiol—osteoporosis	0.000149	0.000536	CcSEcCtD
Bromocriptine—Dermatitis—Estradiol—osteoporosis	0.000148	0.000536	CcSEcCtD
Bromocriptine—Headache—Estradiol—osteoporosis	0.000148	0.000533	CcSEcCtD
Bromocriptine—Nausea—Estradiol—osteoporosis	0.00014	0.000505	CcSEcCtD
Bromocriptine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IRS2—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IRS1—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	1.38e-05	0.000113	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—LEP—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ENO1—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—POMC—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—POMC—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—IDH2—osteoporosis	1.37e-05	0.000112	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IRS1—osteoporosis	1.36e-05	0.000111	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—POMC—osteoporosis	1.36e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.36e-05	0.000111	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.35e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.35e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—LEP—osteoporosis	1.35e-05	0.000111	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PSMA5—osteoporosis	1.35e-05	0.000111	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PSMA2—osteoporosis	1.35e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.35e-05	0.00011	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6R—osteoporosis	1.34e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6R—osteoporosis	1.34e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.33e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.33e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—POMC—osteoporosis	1.33e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.33e-05	0.000109	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.33e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IGF1—osteoporosis	1.32e-05	0.000108	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IGF1—osteoporosis	1.32e-05	0.000108	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.32e-05	0.000108	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.31e-05	0.000107	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—ESR1—osteoporosis	1.31e-05	0.000107	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—POMC—osteoporosis	1.31e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.31e-05	0.000107	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL6—osteoporosis	1.31e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.3e-05	0.000106	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.3e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.3e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.29e-05	0.000106	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—ESR1—osteoporosis	1.29e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GPX1—osteoporosis	1.29e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.29e-05	0.000106	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.29e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.28e-05	0.000105	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6R—osteoporosis	1.28e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.27e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.26e-05	0.000103	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IGF1—osteoporosis	1.26e-05	0.000103	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ACP5—osteoporosis	1.25e-05	0.000102	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.25e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.25e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—LEP—osteoporosis	1.23e-05	0.000101	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.0001	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.22e-05	0.0001	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.22e-05	9.98e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.21e-05	9.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.21e-05	9.88e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IRS1—osteoporosis	1.21e-05	9.88e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.21e-05	9.87e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.2e-05	9.84e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.2e-05	9.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.19e-05	9.75e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.19e-05	9.74e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.18e-05	9.66e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.18e-05	9.65e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—POMC—osteoporosis	1.18e-05	9.64e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.18e-05	9.64e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.17e-05	9.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—POMC—osteoporosis	1.17e-05	9.6e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.17e-05	9.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.17e-05	9.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.17e-05	9.55e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.17e-05	9.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.16e-05	9.52e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—POMC—osteoporosis	1.16e-05	9.52e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TPI1—osteoporosis	1.16e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.15e-05	9.42e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6R—osteoporosis	1.15e-05	9.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.15e-05	9.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.14e-05	9.34e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.14e-05	9.28e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6R—osteoporosis	1.14e-05	9.28e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IGF1—osteoporosis	1.13e-05	9.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.13e-05	9.23e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.13e-05	9.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.12e-05	9.19e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.12e-05	9.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.12e-05	9.15e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IGF1—osteoporosis	1.12e-05	9.15e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.1e-05	9e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.1e-05	8.97e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ENO1—osteoporosis	1.1e-05	8.96e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—P4HB—osteoporosis	1.09e-05	8.95e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.09e-05	8.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.09e-05	8.92e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.08e-05	8.86e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.08e-05	8.83e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.08e-05	8.83e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.07e-05	8.78e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.07e-05	8.78e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—POMC—osteoporosis	1.06e-05	8.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.06e-05	8.66e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.05e-05	8.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.05e-05	8.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.05e-05	8.57e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.05e-05	8.57e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.05e-05	8.55e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.04e-05	8.52e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—LEP—osteoporosis	1.04e-05	8.48e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.03e-05	8.46e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MYC—osteoporosis	1.03e-05	8.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.02e-05	8.38e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	8.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.02e-05	8.35e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.02e-05	8.34e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.02e-05	8.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.02e-05	8.33e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.01e-05	8.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.01e-05	8.26e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.01e-05	8.25e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—osteoporosis	1.01e-05	8.24e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—osteoporosis	1.01e-05	8.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1e-05	8.2e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—osteoporosis	1e-05	8.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—LEP—osteoporosis	9.99e-06	8.17e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ESR1—osteoporosis	9.9e-06	8.09e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6R—osteoporosis	9.89e-06	8.09e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6R—osteoporosis	9.84e-06	8.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—POMC—osteoporosis	9.81e-06	8.03e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—osteoporosis	9.79e-06	8.01e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IGF1—osteoporosis	9.76e-06	7.98e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.74e-06	7.96e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IGF1—osteoporosis	9.71e-06	7.94e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—POMC—osteoporosis	9.66e-06	7.9e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—osteoporosis	9.64e-06	7.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	9.57e-06	7.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	9.53e-06	7.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—POMC—osteoporosis	9.53e-06	7.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	9.48e-06	7.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	9.44e-06	7.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	9.42e-06	7.7e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	9.29e-06	7.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—LEP—osteoporosis	9.28e-06	7.59e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IRS1—osteoporosis	9.25e-06	7.56e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—osteoporosis	9.2e-06	7.52e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IRS1—osteoporosis	9.1e-06	7.44e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ADCY5—osteoporosis	8.96e-06	7.33e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GPX1—osteoporosis	8.93e-06	7.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	8.91e-06	7.29e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—POMC—osteoporosis	8.9e-06	7.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	8.86e-06	7.24e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—POMC—osteoporosis	8.76e-06	7.16e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP19A1—osteoporosis	8.76e-06	7.16e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6R—osteoporosis	8.69e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—osteoporosis	8.68e-06	7.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—POMC—osteoporosis	8.58e-06	7.02e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1—osteoporosis	8.57e-06	7e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	8.56e-06	7e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—osteoporosis	8.56e-06	7e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6R—osteoporosis	8.55e-06	6.99e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ENO1—osteoporosis	8.45e-06	6.91e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1—osteoporosis	8.43e-06	6.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	8.37e-06	6.84e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PSMA5—osteoporosis	8.33e-06	6.81e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PSMA2—osteoporosis	8.33e-06	6.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	8.28e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	8.25e-06	6.75e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—MTHFR—osteoporosis	8.24e-06	6.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—POMC—osteoporosis	7.97e-06	6.52e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MYC—osteoporosis	7.92e-06	6.48e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MYC—osteoporosis	7.91e-06	6.47e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—osteoporosis	7.9e-06	6.46e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.89e-06	6.45e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MYC—osteoporosis	7.86e-06	6.43e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	7.84e-06	6.41e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—osteoporosis	7.8e-06	6.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	7.78e-06	6.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	7.73e-06	6.32e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—osteoporosis	7.71e-06	6.31e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MYC—osteoporosis	7.7e-06	6.29e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—osteoporosis	7.68e-06	6.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	7.67e-06	6.27e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—osteoporosis	7.57e-06	6.19e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—osteoporosis	7.55e-06	6.18e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—osteoporosis	7.46e-06	6.1e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—osteoporosis	7.42e-06	6.07e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—osteoporosis	7.23e-06	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	7.22e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	7.21e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ADCY5—osteoporosis	7.15e-06	5.85e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—osteoporosis	7.13e-06	5.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	7.1e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—osteoporosis	6.82e-06	5.58e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—osteoporosis	6.8e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.76e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—osteoporosis	6.73e-06	5.5e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—osteoporosis	6.73e-06	5.5e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	6.71e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.71e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—osteoporosis	6.59e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—osteoporosis	6.58e-06	5.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—osteoporosis	6.55e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.45e-06	5.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	6.31e-06	5.16e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—osteoporosis	6.13e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	6.11e-06	5e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—osteoporosis	6.07e-06	4.97e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	6.06e-06	4.95e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—osteoporosis	5.95e-06	4.87e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—osteoporosis	5.95e-06	4.86e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—osteoporosis	5.91e-06	4.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	5.86e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—osteoporosis	5.86e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	5.85e-06	4.78e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—osteoporosis	5.83e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	5.82e-06	4.76e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—osteoporosis	5.79e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—osteoporosis	5.69e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—osteoporosis	5.67e-06	4.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	5.66e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—osteoporosis	5.58e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	5.57e-06	4.55e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ADCY5—osteoporosis	5.52e-06	4.52e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—osteoporosis	5.5e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—osteoporosis	5.43e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—osteoporosis	5.26e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—osteoporosis	5.15e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—osteoporosis	5.13e-06	4.2e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—osteoporosis	5.12e-06	4.19e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—osteoporosis	5.08e-06	4.15e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—osteoporosis	5.06e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—osteoporosis	5.06e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—osteoporosis	5.06e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	5.05e-06	4.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—osteoporosis	4.96e-06	4.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	4.95e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—osteoporosis	4.61e-06	3.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—osteoporosis	4.61e-06	3.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	4.6e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—osteoporosis	4.57e-06	3.73e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—osteoporosis	4.41e-06	3.6e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—osteoporosis	4.38e-06	3.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—osteoporosis	4.26e-06	3.49e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—osteoporosis	4.2e-06	3.43e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—osteoporosis	4.06e-06	3.32e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—osteoporosis	3.87e-06	3.16e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—osteoporosis	3.81e-06	3.11e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—osteoporosis	3.73e-06	3.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—osteoporosis	3.46e-06	2.83e-05	CbGpPWpGaD
